Search Results - yongquan+shen

2 Results Sort By:
Selective Clearance of Beta-Amyloid Using Bispecific Recombinant Antibody fragments
Alzheimer’s disease (AD) is one of the most prominent and feared neurodegenerative diseases associated with aging. A hallmark of this disease is the formation of extra-cellular amyloid plaques in the brain. The principle component of these extracellular plaques is amyloid-ß protein (Aß). Though the mechanisms underlying Alzheimer’s...
Published: 4/19/2023   |   Inventor(s): Michael Sierks, Yong Shen
Keywords(s):  
Category(s): Pharmaceuticals, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics
Targeting Podoplanin to Combat Cancer
Sentrimed® is launching its first product, MASL®, to treat and prevent cancer and arthritis. Our technology is protected by issued patents and proprietary technology tailored to combat cancer and inflammatory diseases by targeting a unique receptor, called podoplanin (PDPN), which is expressed by cancer and inflammatory cells. We have received...
Published: 2/16/2024   |   Inventor(s): Gary Goldberg, Yongquan Shen
Keywords(s): Cancer, Compounds, Therapeutic
Category(s): Human Health Care > Therapeutics